Search

Search Constraints

You searched for: Author/Creator Ochoa de Olza, Maria

Search Results

1. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors. Issue 1 (15th March 2020)

2. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

3. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

4. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

5. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

6. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

7. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

8. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

9. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)

10. Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes. Issue 2 (26th August 2020)